CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 100 | -99.1% | 0.00% | – |
| Q2 2021 | $21,000 | -36.4% | 11,600 | -30.5% | 0.00% | – |
| Q1 2021 | $33,000 | -17.5% | 16,683 | -47.6% | 0.00% | – |
| Q4 2020 | $40,000 | -66.1% | 31,817 | -51.5% | 0.00% | – |
| Q3 2020 | $118,000 | -82.8% | 65,557 | -19.7% | 0.00% | -100.0% |
| Q2 2020 | $685,000 | +95.7% | 81,635 | +22.0% | 0.00% | – |
| Q1 2020 | $350,000 | -55.1% | 66,902 | -53.2% | 0.00% | – |
| Q4 2019 | $780,000 | +36.8% | 142,887 | +22.1% | 0.00% | – |
| Q3 2019 | $570,000 | -48.3% | 117,022 | -26.5% | 0.00% | – |
| Q2 2019 | $1,103,000 | +25.6% | 159,141 | +26.0% | 0.00% | – |
| Q1 2019 | $878,000 | +28.6% | 126,326 | +8.1% | 0.00% | – |
| Q4 2018 | $683,000 | -23.3% | 116,835 | -1.0% | 0.00% | – |
| Q3 2018 | $891,000 | +168.4% | 118,013 | +79.4% | 0.00% | – |
| Q2 2018 | $332,000 | -33.5% | 65,774 | -19.7% | 0.00% | – |
| Q1 2018 | $499,000 | +33.4% | 81,878 | +55.6% | 0.00% | – |
| Q4 2017 | $374,000 | +67.7% | 52,633 | +68.5% | 0.00% | – |
| Q3 2017 | $223,000 | +50.7% | 31,243 | +33.0% | 0.00% | – |
| Q2 2017 | $148,000 | -40.3% | 23,492 | -22.0% | 0.00% | – |
| Q1 2017 | $248,000 | – | 30,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |